# Commission Implementing Regulation (EU) 2020/1712 of 16 November 2020 amending Regulation (EU) No 37/2010 to classify the substance lidocaine as regards its maximum residue limit (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘lidocaine’ is replaced by the following:
Pharmacologically active Substance
Marker residue
Animal Species
MRLs
Target Tissues
Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic Classification
‘Lidocaine
NOT APPLICABLE
Equidae
No MRL required
NOT APPLICABLE
For local/regional anaesthesia only.
Local anaesthetic’
Porcine
For use in piglets up to 7 days of age only.
For cutaneous and epilesional use only.
Lidocaine
Bovine
150 μg/kg
200 μg/kg
1 μg/kg
200 μg/kg
30 μg/kg
Muscle
Fat
Liver
Kidney
Milk
NOT APPLICABLE

---
Source: https://www.legislation.gov.uk/eur/2020/1712/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2020-1712/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.